Take our quick online assessment – and download your personalised report.
London Stock Exchange welcomes Verici Dx plc (‘Verici Dx’ or the ‘Company’), a developer of advanced clinical diagnostics for organ transplant, to celebrate the listing of the Company's public shares onto AIM, under the ticker "VRCI".
Verici Dx is an immuno-diagnostics development company, initially focused on the kidney transplantation market. The Company's kidney transplant
London Stock Exchange today welcomes SourceBio International plc (‘SourceBio’ or the ‘Company’), a leading international provider of integrated state-of-the-art laboratory services and products, to celebrate the listing of the Company's public shares onto AIM, under the ticker "SBI".
SourceBio, employs approximately 235 employees across six sites globally, in the UK, Ireland and the U
London Stock Exchange today welcomes Fonix Mobile Plc (“Fonix”), a UK-based founder-led mobile payments and messaging company, to trading on AIM.
The Company has successfully raised £45 million for existing shareholders through a secondary placing, giving it a market capitalisation on Admission of £90 million. It will trade under the ticker FNX.
Fonix’s solutions enable bu
London Stock Exchange today welcomes Calnex Solutions plc (CLX) to AIM.
Calnex designs, produces and markets test instrumentation and solutions for network synchronization and network emulation, enabling its customers to validate the performance of the critical infrastructure associated with the telecoms networks. To date, Calnex has secured and delivered orders from over 600 cu

Marcus Stuttard
Head of UK Primary Markets and AIM

Claire Dorrian
Regional Head of UK Primary Markets

Bod Buckby
Regional Head of UK Primary Markets

Tim Davis
Regional Head of UK Primary Markets